These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38231269)
21. Imaging genetics approach to Parkinson's disease and its correlation with clinical score. Kim M; Kim J; Lee SH; Park H Sci Rep; 2017 Apr; 7():46700. PubMed ID: 28429747 [TBL] [Abstract][Full Text] [Related]
22. Neuroimaging trials of Parkinson's disease progression. Seibyl J; Jennings D; Tabamo R; Marek K J Neurol; 2004 Oct; 251 Suppl 7():vII9-13. PubMed ID: 15505753 [No Abstract] [Full Text] [Related]
23. The Future of Brain Imaging in Parkinson's Disease. Helmich RC; Vaillancourt DE; Brooks DJ J Parkinsons Dis; 2018; 8(s1):S47-S51. PubMed ID: 30584163 [TBL] [Abstract][Full Text] [Related]
24. Mood and neural correlates of excessive daytime sleepiness in Parkinson's disease. Wen MC; Chan LL; Tan LCS; Tan EK Acta Neurol Scand; 2017 Aug; 136(2):84-96. PubMed ID: 28670700 [TBL] [Abstract][Full Text] [Related]
32. Research progress in the early diagnosis of Parkinson's disease. Xie L; Hu L Neurol Sci; 2022 Nov; 43(11):6225-6231. PubMed ID: 35948779 [TBL] [Abstract][Full Text] [Related]
33. Neuroimaging: current role in detecting pre-motor Parkinson's disease. Godau J; Hussl A; Lolekha P; Stoessl AJ; Seppi K Mov Disord; 2012 Apr; 27(5):634-43. PubMed ID: 22508281 [TBL] [Abstract][Full Text] [Related]
34. Cascaded Multi-Column RVFL+ Classifier for Single-Modal Neuroimaging-Based Diagnosis of Parkinson's Disease. Shi J; Xue Z; Dai Y; Peng B; Dong Y; Zhang Q; Zhang Y IEEE Trans Biomed Eng; 2019 Aug; 66(8):2362-2371. PubMed ID: 30582522 [TBL] [Abstract][Full Text] [Related]
35. The role of neuroimaging in the early diagnosis and evaluation of Parkinson's disease. Seibyl J; Jennings D; Tabamo R; Marek K Minerva Med; 2005 Oct; 96(5):353-64. PubMed ID: 16227950 [TBL] [Abstract][Full Text] [Related]
36. Patterned cortical atrophy in early Parkinson's Disease: The potential for unbiased, data driven neuroimaging to detect structural changes in de novo patients. Walsh RR Parkinsonism Relat Disord; 2018 May; 50():1-2. PubMed ID: 29643008 [No Abstract] [Full Text] [Related]
37. A task-specific cognitive domain decline is correlated with plasma and neuroimaging markers in patients with Parkinson's disease. Li CH; Chen TF; Peng PL; Lin CH J Neurol; 2022 Dec; 269(12):6530-6543. PubMed ID: 35965282 [TBL] [Abstract][Full Text] [Related]
38. Neuroimaging of Parkinson's disease by quantitative susceptibility mapping. Guan X; Lancione M; Ayton S; Dusek P; Langkammer C; Zhang M Neuroimage; 2024 Apr; 289():120547. PubMed ID: 38373677 [TBL] [Abstract][Full Text] [Related]
39. Neuroimaging approaches to cognition in Parkinson's disease. Montaser-Kouhsari L; Young CB; Poston KL Prog Brain Res; 2022; 269(1):257-286. PubMed ID: 35248197 [TBL] [Abstract][Full Text] [Related]
40. Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease: A Review. Mitchell T; Lehéricy S; Chiu SY; Strafella AP; Stoessl AJ; Vaillancourt DE JAMA Neurol; 2021 Oct; 78(10):1262-1272. PubMed ID: 34459865 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]